Summary: Poly(ADP-ribose) polymerase (PARP) , or poly (ADP-ribose) synthetase, is a nuclear enzyme that consumes NAD when activated by DNA damage. The role of PARP in the pathogenesis of traumatic brain injury (TBI) is unknown. Using a controlled cor t ical impact (CCI) model of TBI and mice deficient in PARP, the authors studied the effect of PARP on functional and histologic outcome after CCI using two proto cols. In protocol 1, naiVe mice (n = 7 +/+, n = 6 -/-) were evaluated for motor and memory acquisition before CCI. Mice were then subjected to severe CCI and killed at 24 hours for immunohistochemical detection of nitrated tyrosine, an indica tor of peroxynitrite formation. Motor and memory performance Poly(ADP-ribose) polymerase (PARP) or poly ADP ribose synthetase is a highly conserved, abundant nuclear enzyme that has been hypothesized to play a role in genomic surveillance and stability, cellular growth and differentiation, and repair of DNA damage (Althaus and Richter, 1987; de Murcia et aI., 1994). After its activa tion by DNA strand breaks, P ARP binds to damaged DNA and catalyzes the addition of ADP-ribose units to a Received May 14, 1999; accepted June 3, 1999. This work was supported in part by Grants from the National Insti tutes of Health to D. Marion, P. Kochanek, and C.E. Dixon (NS 30318), and G. Hasko (R43 NS37985).
did not differ between na'ive PARP +/+ and -/-mice. Both groups showed nitrotyrosine staining in the contusion, suggest ing that peroxynitrite is produced in contused brain. In protocol 2, mice (pARP +/+, n = 8; PARP -/-, n = 10) subjected to CCI were tested for motor and memory function, and contusion volume was determined by image analysis. PARP -/-mice demonstrated improved motor and memory function after CCI versus PARP +/+ mice (P < 0.05). However, contusion volume was not different between groups. The results suggest a detri mental effect of P ARP on functional outcome after TBI. Key Words: Brain injury-Poly(ADP-ribose) polymerase Controlled cortical impact-Mice. number of nuclear proteins including P ARP itself, using nicotinamide adenine-dinucleotide (NAD+) as substrate. ADP-ribosylation of chromosomal proteins may facili tate DNA repair by a number of mechanisms that include promotion of structural changes in chromatin and inhi bition of inappropriate transcription and recombination of damaged DNA (Berger, 1985; Althaus and Richter, 1987; Satoh and Lindahl, 1992) . However, overactiva tion of PARP by extensive DNA damage can lead to rapid consumption of NAD, depletion of ATP, and cell death by energy failure (Berger, 1985; Gaal et aI., 1987) . Hydroxyl radical and peroxynitrite (a reactive oxidant species produced from the reaction of superoxide and nitric oxide) are key endogenous triggers of PARP acti vation in numerous pathologic conditions (Szabo and Dawson, 1998) .
DNA damage may be produced after traumatic brain injury (TEl) by direct mechanical injury, reactive oxygen species such as peroxynitrite, and by activation of en-dogenous endonucleases (Rink et aI., 1995; Clark et aI., 1997 a; Nishio et aI., 1997; Shohami et aI., 1997) . DNA damage has been reported in neurons in CA l, CA3, den tate gyrus, cortex, and other brain regions between 4 hours and 4 weeks after experimental TBI (Rink et aI., 1995; Colicos and Dash, 1996; Clark et aI., 1 997a,b; Conti et aI., 1998; Yakovlev et aI., 1997; Whalen et al., 1999b) . DNA damage early after TBI would be a potent stimulus for P ARP activation; DNA damage in cells in jured after TBI could induce energy failure through ex tensive activation of P ARP.
Exposure of neurons and other cell types to glutamate or reactive oxygen species in vitro induces DNA damage and cell death mediated by P ARP activation and energy failure (Thies and Autor, 1991; Wallis et al., 1993; Cosi et aI., 1994; Radons et aI., 1994; Zhang et aI., 1994; Cookson et aI., 1998) . Recent studies in experimental stroke show that induction of neuronal nitric oxide syn thase and formation of peroxynitrite precede P ARP ac tivation, and that ischemic cell death is mediated in part by P ARP activation in vivo (Endres et aI., 1997; Taka hashi et aI., 1997; Endres et aI., 1998a; Tokime et aI., 1998) . These studies have led to the "P ARP suicide hy pothesis" in the setting of ischemia when energy failure is a key initiator of necrotic cell death (Eliasson et aI., 1997; Endres et aI., 1997) .
Excitotoxicity and production of DNA damaging agents such as oxygen free radicals and peroxynitrite are relevant to the pathogenesis of TBI (McIntosh, 1993; Palmer et aI., 1993; Globus et aI., 1995; Gong et aI., 1995; Rink et aI., 1995; Verweij et aI., 1997; Yakovlev et aI., 1997) . Inhibitors of ADP-ribosylation protect hippo campal slices against percussion TBI-induced loss of CAl evoked response in vitro, suggesting that PARP activation might contribute to loss of neuronal function after TBI (Wallis et aI., 1996) . Recent studies implicate PARP activation in the pathogenesis of CNS autoim mune and neurodegenerative diseases, and traumatic spi nal cord injury (Hivert et aI., 1998; Scott et aI., 1999) . Poly(ADP-ribose) polymerase activation has been ob served in brain after fluid percussion in rats in a prelimi nary report (LaPlaca et aI., 1998) ; however, the role of P ARP in the pathogenesis of TBI is unknown.
The use of mice genetically deficient in P ARP is a powerful strategy to study the role of P ARP in the patho genesis of TBI. The use of knockout mice completely eliminates P ARP function and avoids the potential dis advantages of nonspecific P ARP inhibitors. Based on evidence for a detrimental role of PARP activation in several models of CNS injury, we hypothesized that, 
METHODS

Mice
All experiments were approved by the University of Pitts burgh Institutional Animal Care and Use Committee and com plied with the NIH Guide for the Care and Use of Laboratory Animals. Mice were given free access to food and water and were housed in laminar flow racks in a temperature-controlled room with 12 hour day/night cycles.
Homozygous male (P ARP -/-) and P ARP +/+ litter mate controls consisting of a mixed genetic background of SV129 and C57BLl6 were generated as previously described (Wang et aI., 1995) , bred in an animal facility, and used at 12 to 13 weeks of age (23 to 38 g). PARP -/-mice were produced by deletion of part of the second exon and intron by standard techniques of homologous recombination in embryonic stem cells and the mice were genotyped as described in Wang et al. (1995) . Poly (ADP-ribose) polymerase -/-mice develop normally, are fer tile, and are phenotypically normal (Wang et aI., 1995) .
Experimental protocols
Two experimental protocols were used. To exclude inherent differences in motor function and learning between PARP +/+ and -/-mice, the first protocol compared the performance of naIve mice (PARP +/+, n = 7 versus PARP -/-, n = 6) in tests of motor (day I) and memory (days 6 to 13) function described below. NaIve mice were then subjected to CCI and evaluated at 24 hours for immunohistochemical detection of nitrotyrosine, a marker for peroxynitrite, in contused brain regions. The second protocol compared the effect of CCI on motor and memory outcome in PARP +/+ (n = 8) versus PARP -/-(n = 10) mice. No preinjury training was used for Morris water maze (MWM) testing. Contusion volume in the injured (left) hemi sphere, and left and right lateral ventricles and hemispheric volumes were also evaluated at 21 days in both groups.
Controlled cortical impact
The mouse CCI model was used as previously described (Smith et aI., 1995) with minor modifications (Whalen et aI., 1999a) . Mice were anesthetized with 2% isoflurane (Anaquest, Memphis, TN, U.S.A.), N20 and O2 (2: 1) and placed in a stereotactic frame. Brain temperature was monitored by a probe (0.009-inch diameter; Physitemp, Clifton, NJ, U.S.A.) inserted through a bur hole into the left frontal cortex, and body tem perature was monitored by a rectal probe. A 5-mm craniotomy was performed over the left parietotemporal cortex, the bone flap was removed, and brain temperature was maintained at 37.5 ± 0.5°C for 5 minutes. Controlled cortical impact was then produced using a pneumatic cylinder (Bimba, Monee, IL, U.S.A.) with a 3-mm flat-tip impounder, velocity 6.0 ± 0.2 mis, and depth of 1.2 mm. The bone flap was replaced and sealed immediately after CCI (Koldmount cement, Vernon Benshoff, Albany, NY, U.S.A.) and the scalp was sutured closed. Mice were allowed to recover from anesthesia in an oxygen hood for 30 minutes then returned to their cages.
Preparation of brain tissue for immunohistochemistry
At 24 hours after CCI, mice were anesthetized with isoflu rane and transcardially perfused with 100 mL of 4% paraform aldehyde. The brain was rapidly removed intact and frozen at -70°C. Coronal sections (10 !-Lm) were placed on polY-L-lysine slides using a cryostat and stored at -20°C for batch analysis.
Immunohistochemistry (nitrotyrosine detection)
Nitrotyrosine was detected immunohistochemically in brain sections as an indicator of the presence of peroxynitrite and other nitrosating agents, as previously described (Scott et aI., 1999) . Endogenous peroxidase was quenched for 15 minutes with 0.3% hydrogen peroxide in methanol. Nonspecific binding was minimized by incubating the sections in 2% normal goat serum in phosphate buffered saline for I hour. Sections were then incubated overnight with 1 :500 dilution of primary anti nitrotyrosine antibody (Upstate Biotechnology, Lake Placid, NY, U.S.A.), and specific labeling was detected with a biotin conjugated goat antirabbit IgG and avidin-biotin peroxidase complex (Vectastain Elite ABC kit, Vector Laboratories, Bur lingame, CA, U.S.A.).
Assessment of motor function
Gross vestibulomotor function was assessed at I day after injury using a beam balance (Feeney et aI., 1981; Dixon et aI., 1987) test. The beam balance task consisted of placing the mouse on a suspended I.O-cm wide wooden beam and record ing the time the mouse remained on the beam for up to 60 seconds. Mice were trained prior to CCI in three trials during which baseline measurements of time on the beam were made.
Spatial memory acquisition assessment
Experimenters blinded to mouse genotype evaluated spatial memory performance of mice using the MWM task as previ ously described (Hamm et aI., 1992; Long et aI., 1996) . A white pool (83 cm diameter, 60 cm deep) was filled with water to 29 cm depth. Several highly visible extramaze cues that remained constant throughout the trials were located around the pool. Water temperature was maintained approximately 24°C. The goal platform (a round, white wooden platform 10 cm in di ameter) was positioned 1 cm below the surface of the water approximately 15 em from the southwest wall. A video tracking system mounted above the pool (Chromotrack 3.0, San Diego Instruments, San Diego, CA, U.S.A.) recorded the swimming movements of the mice. To ensure recovery from motor defi cits, testing was performed on days 14 through 20 after CCI. Each mouse was subjected to a series of four trials per day. For each trial, mice were randomized to one of four starting loca tions (north, south, east, west) and placed in the pool facing the wall. Mice were given a maximum 120 seconds to find the submerged platform. If the mouse failed to reach the platform by 120 seconds, it was placed on the platform by the experi menter and allowed to remain there for 30 seconds. Mice were placed in a 37°C incubator for 4 minutes between trials. To exclude differences in visual acuity between P ARP +/+ and PARP -/-mice, testing was performed on a platform I cm above the surface of the water on days 19 and 20 after injury. Mouse performance in the MWM was quantitated by latency to find the platform. Probe trials were used to measure place memory. The mice were placed in the maze without the plat form and the video tracking system was used to measure the percent time that the animal swam in the quadrant that previ ously contained the platform.
The swim speeds of P ARP +/+ and P ARP -/-mice were determined for each mouse on the first day of MWM testing by dividing the sum of the total distance that the mice swam dur ing the four trials by the total swim time.
Lesion volume
Morphometric image analysis (MClD, Imaging Research, St. Catherines, Ontario, Canada) was used to determine contusion, ventricular, and hemispheric volumes at 21 days after CCl. Mice were anesthetized with isoflurane and transcardially per fused with 4% paraformaldehyde. Coronal sections (20 j-Lm) were cut at 0.5 mm distances from the anterior to the posterior brain and mounted on poIY-L-lysine-coated slides. At each 0.5 mm interval, four sections were obtained and stained with cre syl violet. The areas of the lesion, left lateral ventricle, and injured and noninjured hemispheres were determined using im age analysis. An average area of the lesion, left lateral ventricle, and intact hemispheric tissue was obtained from each slice. From these data, corresponding lesion, ventricular, and hemi spheric volumes were calculated. Contusion volume was ex pressed both in mm 3 in the injured hemisphere, and as a per centage of the volume of the noninjured hemisphere. Ventricu lar and hemispheric volume were expressed in mm 3 .
Statistical analyses
Data are mean ± SD. Body weight, brain temperature, swim speed, and volumetric data were analyzed by t-test. Morris water maze acquisition times in naIve and injured P ARP +/+ and -/-mice were analyzed by analysis of variance for re peated measures (group x time). Between group differences were analyzed by post hoc comparisons at each timepoint. Probe trial results were analyzed by one-way analysis of vari ance. Performance on the beam balance test was analyzed by analysis of variance followed by the appropriate post hoc test. For each test, P < 0.05 was considered significant.
RESULTS
Protocol I. Behavior assessment in naive mice and posttraumatic immunohistochemistry
NaIve PARP +/+ and -/-mice performed equally well in the beam balance (Fig. 1) test. The data in Figs. 1 and 2 contain results for both naIve and injured (see below, protocol II) mice to facilitate comparison. NaIve PARP +/+ and -/-mice also performed equally well in the spatial memory acquisition paradigm (Fig. 2) . Also, per formance in the probe trials, measured by the percentage of time spent by the mice in the target quadrant, did not differ between naIve PARP +/+ (32.8 ± 4.0 %) and PARP -/-(32.4 ± 1.9 %) mice. Similarly, swim speed did not differ between naIve PARP +/+ (20.7 ± 1.9 cm/s) and PARP -/-(2l.3 ± l.3 cm/s) mice.
All mice survived TBI with 24-hour outcome. Figure  3 shows the results of immunohistochemical detection of nitrotyrosine in representative brain sections from P ARP +/+ and -/-mice at 24 hours after eel. Nitrotyrosine, an indicator of peroxynitrite formation, was detected in the brain of both PARP +/+ and PARP -/-mice in the area adjacent to the contusion, whereas no staining was ob served in uninjured brain regions. There were no quali tative differences in the degree of staining between P ARP +/+ and P ARP -/-mice. Omission of the primary nitrotyrosine antibody resulted in complete absence of immunoreactivity (data not shown).
Protocol II. Behavior and histopathologic outcome after controlled cortical impact
Seventeen of the eighteen mice survived the 21-day trauma protocol. Body weight did not differ between PARP +/+ (29.6 ± 4.4 g) and PARP -/-(30.6 ± 4. 1 g) mice before eel.
Beam balance (Fig. 1) performance was significantly impaired in PARP +/+ and -/-mice compared to naIve mice. In addition, PARP +/+ mice performed signifi cantly worse than P ARP -/-on the beam balance test after eel (P < 0.05; Fig. 1 ).
Latency to find the hidden platform in the MWM test was increased in both P ARP +/+ and -/-mice compared with naIve mice (P < 0.05). In addition, MWM perfor mance was significantly worse in P ARP +/+ versus -/ mice (P < 0.05; Fig. 2) . In contrast to the results with naIve mice, performance in the probe trials was impaired tween groups (Fig. 2) . Swim speeds (cm/s) did not differ between injured PARP +/+ (18.7 ± 1. 1) and PARP -/ (20. 1 ± 1.0) mice.
Contusion volume expressed in mm 3 (PARP +/+, 21.0 1 ± 3.16; PARP -/-, 17.57 ± 1.57) or as percent injured hemisphere (PARP +/+, 9.84 ± 1.45; PARP -/-, 9.37 ± 0.86) did not differ between groups. Similarly, left ventricular volume did not differ between P ARP +/+ (2.0 1 ± 0.25 mm 3 ) and -/-(2.41 ± 0.2 1 mm 3 ) mice. However, right (noninjured) hemispheric volume was less in P ARP -/-(222.62 ± 6.56 mm 3 ) compared with PARP +/+ (254. 19 ± 11.79 mm 3 ) mice (P < 0.05).
DISCUSSION
The main finding of this study is that mice deficient in PARP show protection from functional deficits after se vere CCI. The effect of P ARP deletion was evident early after TBl because PARP -/-mice performed signifi cantly better than wild-type mice (P ARP +/+) in the mo tor function tests on day 1 after injury. In addition, the beneficial effect of PARP depletion on memory acquisi tion was observed on days 16 and 18 after TBI, suggest ing a sustained effect. The data are not explained by innate differences in learning, motor performance, visual acuity, or swim , speed in naive PARP -/-mice versus +/+ mice. The beneficial effect on functional outcome was seen despite no significant benefit of P ARP deletion on histopathologic outcome. This is the first examination of the role of P ARP in an in vivo model of TBI using measures of functional out come. A single study showing a modest beneficial effect on motor function at 24 hours after cerebral ischemia in PARP -/-versus +/+ mice and in mice treated with pharmacologic inhibitors of P ARP has been reported (Endres et aI., 1997) . However, several studies have shown a dramatic decrease in infarct size in P ARP -/ versus +/+ mice, suggesting a powerful detrimental ef fect of P ARP after experimental stroke (Eliasson et aI., 1997; Endres et aI., 1997; Endres et aI., 1998a) . In vitro studies using hippocampal slices suggested a role for PARP activation in the loss of CA 1 evoked potentials after fluid percussion injury because addition of P ARP inhibitors restored electrophysiologic function (Wallis et ai., 1996) . Recent studies in rats have shown PARP ac tivation at 24 hours after spinal cord injury (Scott et aI., 1999) and within 2 hours after fluid percussion brain injury (LaPlaca et aI., 1998) ; however functional out come was not reported in these studies. In our study, there seemed to be a dissociation between histologic and functional outcome in P ARP -/-mice after CCI. Con tusion volume is a refractory therapeutic endpoint that is relatively difficult to manipulate in the CCI model (Clark et aI., 1997b; Dixon et aI., 1998; Whalen et a!., 1998 Whalen et a!., ,1999a .
One mechanism by which P ARP -/-mice may be protected from functional deficits is by inhibition of posttraumatic energy failure. After TBI, endogenous en donucleases and reactive oxygen species contribute to DNA damage. DNA single strand breaks are detectable in injured brain regions early after CCI in rats (Whalen et aI., 1999b) . DNA damage-initiated activation of PARP could lead to consumption of NAD and depletion of ATP, ultimately causing energy failure and cell death (Yamamoto et aI., 1981; Schraufstatter et aI., 1986) . Nu merous in vitro studies implicate PARP activation and energy failure in the necrotic death of neurons and as trocytes exposed to excitotoxic or oxidizing agents, as inhibition or deletion of P ARP prevents depletion of NAD and cell death (Wallis et aI., 1993; Cosi et aI., 1994; Zhang et aI., 1994 Zhang et aI., , 1995 Eliasson et aI., 1997; Szabo, 1997; Endres et aI., 1998b) .
We demonstrated the formation of nitrotyrosine at 24 hours after CCI in contused brain. Robust nitrotyrosine staining in and around the contusion site in both P ARP +/+ and P ARP -/-mice supports a role for peroxynitrite, a known PARP activator (Szabo et aI., 1998) , in the pathogenesis of cell death and/or injury after CCI. Ni trotyrosine is a relatively specific marker of oxidative damage to proteins by peroxynitrite. Thus, it is possible that peroxynitrite generation is also producing oxidative DNA damage after TBI. In early stroke, poly ADP ribose formation was abolished by the genetic inactiva tion of the neuronal isoform of NOS (Endres et aI., 1998a) . Peroxynitrite formation via neuronal NOS activ ity may also be involved in the pathogenesis of TBI. However, these results must be interpreted with caution because recent data suggest that nitration of tyrosine resi dues may also occur by reaction with oxygen radicals other than peroxynitrite (Sampson et aI., 1998) .
Severe TBl, both experimentally and clinically, ini tiates a cascade of events that result in acute energy failure, including the release of excitatory amino acids, direct cellular disruption, and local ischemia (Hayes et aI., 1992; Hovda et aI., 1995; Adelson et aI., 1997) . This results in sustained depression of bioenergetic status (Headrick et aI., 1994) and formation of purine degrada tion products (Bell et aI., 1996) . It is likely that these events are additive in the setting of NAD depletion by P ARP activation after TBI.
Poly(ADP-ribose) polymerase inhibition or deletion reduces infarction volume up to 80% in models of cere bral ischemia (Eliasson et aI., 1997; Endres et aI., 1997; Takahashi et aI., 1997; Endres et aI., 1998b) . Energy failure is an important component of the pathophysiol ogy of both cerebral ischemia and TBI. Poly(ADP ribose) polymerase has also been hypothesized to play a role in neurodegenerative diseases mediated by the for mation of oxygen free radicals and cellular energy deple tion, such as excitotoxic neuronal degeneration (Mel-drum and Garthwaite, 1990 ) and l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced catecholamine depletion in brain (Cosi et aI., 1997) . Mechanisms other than energy failure, such as inhibition of enzymes by ribosylation, may also play a role in PARP-mediated neural injury.
Interpretation of our results depends on the demon stration that functional P ARP activity and alternate path ways of ADP-ribosylation are absent in P ARP -/-mice. Poly(ADP-ribose) polymerase -/-mice used in this study lack normal length P ARP transcripts and P ARP activity in brain and other tissues (Wang et aI., 1995) . In addition, poly (ADP-ribose) polymers were not detected after DNA damage in fibroblasts from P ARP -/-mice (Wang et aI., 1995) . Nevertheless, interpretation of any results using the P ARP -/-mice will be complicated by the fact that P ARP -/-cells can produce significant, albeit small levels of poly ADP-ribose polymers and novel, additional PARP-like enzymes have been recently identified (Shieh et aI., 1998; Smith et aI., 1998) .
One potential confounding result of this study is the previously unreported finding that hemispheric volume is approximately 10% less in P ARP -/-versus +/+ mice. However, physical deformation of the brain by 1.2 mm via CCI in both groups would be expected to bias the insult agaiqst the P ARP -/-group. The smaller hemi spheric volume in P ARP -/-mice is not explained by differences in body weight between P ARP -/-and +/+ mice used in this study. We have previously shown that this injury does not lead to volume loss in the contralat eral hemisphere (Whalen et aI., 1999a) . Despite the ob served differences in brain volume, no differences in motor, visual, or cognitive testing were observed be tween naive P ARP -/-and +/+ mice.
Our study shows a detrimental role for P ARP in the pathogenesis of TBI. This finding is impressive in light of the lack of an effect on functional outcome of other treatment strategies in the CCI model targeting a variety of other mechanisms in our laboratory. No effect on functional outcome or contusion volume was observed after CCI in mice deficient in intercellular adhesion mol ecule-I (Whalen et ai., 1999a) and interleukin-8 receptor homologue versus respective wild-type mice (Whalen et ai., 1998) . In addition, motor and memory function were actually worse after CCI in mice deficient in inducible nitric oxide synthase versus wild-type, indicating an en dogenous neuroprotectant role for inducible nitric oxide synthase (Sinz et aI., 1997) . Similarly, TNF-a knockout mice exhibited worse cognitive outcome versus wild type at 7 to 28 days after CCI (Scherbel et ai., 1997) .
In conclusion, we have shown for the first time a det rimental effect of P ARP on functional outcome after TBI. Further studies are needed to confirm these results and define the mechanisms responsible for the observed effects. Pharmacological inhibition of P ARP may repre-J Cereb Blood Flow Metab. Vol. 19, No.8, 1999 sent a therapeutic strategy for reducing neurologic injury after TBI in patients.
